Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.
about
The choice of regimens based on bortezomib for patients with newly diagnosed multiple myelomaA multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trialThe risk factors for herpes zoster in bortezomib treatment in patients with multiple myelomaThalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study.Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma.
P2860
Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bortezomib in combination with ...... myeloma: a Chinese experience.
@ast
Bortezomib in combination with ...... myeloma: a Chinese experience.
@en
type
label
Bortezomib in combination with ...... myeloma: a Chinese experience.
@ast
Bortezomib in combination with ...... myeloma: a Chinese experience.
@en
prefLabel
Bortezomib in combination with ...... myeloma: a Chinese experience.
@ast
Bortezomib in combination with ...... myeloma: a Chinese experience.
@en
P2093
P1433
P1476
Bortezomib in combination with ...... myeloma: a Chinese experience.
@en
P2093
Guoqing Wei
Jingsong He
Maofang Lin
Wanzhuo Xie
Weijia Huang
Weiyan Zheng
P304
P356
10.1016/J.LEUKRES.2009.04.006
P577
2009-12-01T00:00:00Z